{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:37:24Z","timestamp":1791823044381,"version":"4.3.4"},"reference-count":134,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.psychres.2014.01.011","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T16:31:24Z","timestamp":1390062684000},"page":"497-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Is elevated norepinephrine an etiological factor in some cases of schizophrenia?"],"prefix":"10.1016","volume":"215","author":[{"given":"Paul J.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2014.01.011_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/026988119701100110","article-title":"Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by \u2018prepulses\u2019 in man","volume":"11","author":"Abduljawad","year":"1997","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib2","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/npp.2011.47","article-title":"Pharmacological stimulation of locus coeruleus reveals a new antipsychotic-responsive pathway for deficient sensorimotor gating","volume":"36","author":"Alsene","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib3","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1038\/npp.2010.106","article-title":"Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine","volume":"35","author":"Alsene","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1471-4159.2003.02044.x","article-title":"Stimulation of alpha1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs","volume":"87","author":"Amargos-Bosch","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.psychres.2014.01.011_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00213-003-1724-3","article-title":"Adrenergic targets for the treatment of cognitive deficits in schizophrenia","volume":"174","author":"Arnsten","year":"2004","journal-title":"Psychopharmacology (Berlin)"},{"issue":"1","key":"10.1016\/j.psychres.2014.01.011_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00023210-200923000-00005","article-title":"Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction","volume":"23","author":"Arnsten","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2014.01.011_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijdevneu.2011.02.006","article-title":"Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia","volume":"29","author":"Arnsten","year":"2011","journal-title":"International Journal of Developmental Neuroscience"},{"key":"10.1016\/j.psychres.2014.01.011_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0197-4580(93)90044-C","article-title":"Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: indirect effects of yohimbine versus direct effects of clonidine","volume":"14","author":"Arnsten","year":"1993","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.psychres.2014.01.011_bib9","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1523\/JNEUROSCI.08-11-04287.1988","article-title":"The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes","volume":"8","author":"Arnsten","year":"1988","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.psychres.2014.01.011_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0091-3057(96)00477-7","article-title":"The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys","volume":"58","author":"Arnsten","year":"1997","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.psychres.2014.01.011_bib11","first-page":"45","article-title":"Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale","volume":"85","author":"Arnsten","year":"2012","journal-title":"Yale Journal of Biology and Medicine"},{"key":"10.1016\/j.psychres.2014.01.011_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0079-6123(00)26013-5","article-title":"Locus coeruleus and regulation of behavioral flexibility and attention","volume":"126","author":"Aston-Jones","year":"2000","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.gene.2013.01.031","article-title":"Association between 1603C>T polymorphism of DBH gene and bipolar disorder in a Turkish population","volume":"519","author":"Ates","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.psychres.2014.01.011_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11632020-000000000-00000","article-title":"Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?","volume":"26","author":"Attard","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2014.01.011_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1192\/bjp.142.4.422","article-title":"Phaeochromocytoma with schizophreniform psychosis","volume":"142","author":"Bahemuka","year":"1983","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0022-3565(24)37049-1","article-title":"Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist","volume":"283","author":"Bakshi","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.psychres.2014.01.011_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0306-4522(98)00752-0","article-title":"Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats","volume":"92","author":"Bakshi","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2014.01.011_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tics.2011.11.015","article-title":"Cognition in schizophrenia: core psychological and neural mechanisms","volume":"16","author":"Barch","year":"2012","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1016\/j.psychres.2014.01.011_bib19","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1017\/S0033291705005702","article-title":"Normal levels of prepulse inhibition in the euthymic phase of bipolar disorder","volume":"35","author":"Barrett","year":"2005","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.psychres.2014.01.011_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.schres.2008.10.016","article-title":"Medical comorbidity in patients with schizophrenia and alcohol dependence","volume":"107","author":"Batki","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.psychres.2007.06.001","article-title":"Patterns of stress in schizophrenia","volume":"160","author":"Betensky","year":"2008","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib22","first-page":"1377","article-title":"Catecholamines and their receptors in blood: evidence for alterations in schizophrenia","volume":"19","author":"Bondy","year":"1984","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib23","first-page":"217","article-title":"A new animal model for schizophrenia: interactions with adrenergic mechanisms","volume":"13","author":"Borison","year":"1978","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-1781(94)90052-3","article-title":"Noradrenergic and dopaminergic interrelation in schizophrenia","volume":"53","author":"Brambilla","year":"1994","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/1097-4679(199305)49:3<447::AID-JCLP2270490321>3.0.CO;2-4","article-title":"Gestational and neonatal factors in the etiology of schizophrenia","volume":"49","author":"Brixey","year":"1993","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.psychres.2014.01.011_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0028-3908(98)00051-3","article-title":"Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats","volume":"37","author":"Carasso","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1176\/appi.ajp.159.4.539","article-title":"A twin study of genetic relationships between psychotic symptoms","volume":"159","author":"Cardno","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S003329170000622X","article-title":"Does dopamine play a role in schizophrenia?","volume":"7","author":"Carlsson","year":"1977","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.psychres.2014.01.011_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.31887\/DCNS.2006.8.1\/acarlsson","article-title":"A dopaminergic deficit hypothesis of schizophrenia: the path to discovery","volume":"8","author":"Carlsson","year":"2006","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.psychres.2014.01.011_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0024-3205(97)00228-2","article-title":"Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications","volume":"61","author":"Carlsson","year":"1997","journal-title":"Life Sciences"},{"key":"10.1016\/j.psychres.2014.01.011_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01255820","article-title":"Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice","volume":"77","author":"Carlsson","year":"1989","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.psychres.2014.01.011_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-5618.2007.00415.x","article-title":"Sensorimotor gating in manic and mixed episode bipolar disorder","volume":"9","author":"Carroll","year":"2007","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.psychres.2014.01.011_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1440-1819.2007.01722.x","article-title":"Sociodemographic and clinical factors associated with relapse in schizophrenia","volume":"61","author":"Chabungbam","year":"2007","journal-title":"Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.psychres.2014.01.011_bib34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0269881113480988","article-title":"Noradrenergic modulation of cognition: therapeutic implications","volume":"27","author":"Chamberlain","year":"2013","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0006-3223(90)90442-5","article-title":"Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept","volume":"27","author":"Chang","year":"1990","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib36","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1176\/ps.2006.57.8.1102","article-title":"Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia","volume":"57","author":"Chwastiak","year":"2006","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.psychres.2014.01.011_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/JGP.0b013e318211817e","article-title":"The relationship between trauma and clinical outcome variables among older adults with schizophrenia spectrum disorders","volume":"20","author":"Cohen","year":"2012","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","article-title":"Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia","volume":"1003","author":"Coyle","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.psychres.2014.01.011_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000117988","article-title":"Plasma noradrenaline and clinical psychopathology in schizophrenia. A correlation analysis","volume":"10","author":"Dajas","year":"1983","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2014.01.011_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00174500","article-title":"Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex","volume":"95","author":"Davis","year":"1988","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.psychres.2014.01.011_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1037\/0033-295X.96.1.84","article-title":"Arousal and physiological toughness: implications for mental and physical health","volume":"96","author":"Dienstbier","year":"1989","journal-title":"Psychological Review"},{"key":"10.1016\/j.psychres.2014.01.011_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1192\/bjp.147.6.623","article-title":"The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia","volume":"147","author":"Eccleston","year":"1985","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(97)00149-7","article-title":"The effects of an early stressful life event on sensorimotor gating in adult rats","volume":"30","author":"Ellenbroek","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fnmol.2012.00033","article-title":"AKT\/GSK3 signaling pathway and schizophrenia","volume":"5","author":"Emamian","year":"2012","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/j.psychres.2014.01.011_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0920-9964(88)90024-2","article-title":"Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings","volume":"1","author":"Fields","year":"1988","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-010-1856-1","article-title":"A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex?","volume":"213","author":"Fitzgerald","year":"2011","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.psychres.2014.01.011_bib47","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.mehy.2012.02.025","article-title":"Neurodrinking: is alcohol a substrate in a novel, endogenous synthetic pathway for norepinephrine?","volume":"78","author":"Fitzgerald","year":"2012","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.psychres.2014.01.011_bib48","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1523\/JNEUROSCI.22-19-08771.2002","article-title":"Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine","volume":"22","author":"Franowicz","year":"2002","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.psychres.2014.01.011_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0447.1982.tb00819.x","article-title":"Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs","volume":"65","author":"Freedman","year":"1982","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2014.01.011_bib50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0893-133X(01)00249-4","article-title":"Guanfacine treatment of cognitive impairment in schizophrenia","volume":"25","author":"Friedman","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib51","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1176\/appi.ajp.2010.09091328","article-title":"The effects of hypertension and body mass index on cognition in schizophrenia","volume":"167","author":"Friedman","year":"2010","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2002-25027","article-title":"A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients","volume":"35","author":"Gaertner","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0447.1982.tb06717.x","article-title":"CSF monoamine metabolites in schizophrenic patients","volume":"66","author":"Gattaz","year":"1982","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2014.01.011_bib54","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.biopsych.2006.12.002","article-title":"Evidence of disrupted prepulse inhibition in unaffected siblings of bipolar disorder patients","volume":"62","author":"Giakoumaki","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2014.01.011_bib56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(93)90351-H","article-title":"Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area","volume":"233","author":"Grenhoff","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0091-3057(02)01047-X","article-title":"Rapid habituation of hippocampal serotonin and norepinephrine release and anxiety-related behaviors, but not plasma corticosterone levels, to repeated footshock stress in rats","volume":"74","author":"Hajos-Korcsok","year":"2003","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.psychres.2014.01.011_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.1995.03950130029004","article-title":"Pharmacotherapy of impaired affect in recovering schizophrenic patients","volume":"52","author":"Hogarty","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(84)90068-4","article-title":"Prazosin, a specific alpha 1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patients","volume":"11","author":"Hommer","year":"1984","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib60","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.schres.2013.04.035","article-title":"Association between DBH 19bp insertion\/deletion polymorphism and cognition in first-episode schizophrenic patients","volume":"147","author":"Hui","year":"2013","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib61","first-page":"479","article-title":"The course of treatment in schizophrenia in relation to the presence of affective disturbances","volume":"15","author":"Jaroszynski","year":"1975","journal-title":"Polish Medical Science and History Bulletin"},{"key":"10.1016\/j.psychres.2014.01.011_bib62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2008.10.006","article-title":"Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype","volume":"1246","author":"Jentsch","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1098-2396(199801)28:1<21::AID-SYN3>3.0.CO;2-E","article-title":"Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex","volume":"28","author":"Jentsch","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.psychres.2014.01.011_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3371\/CSRP.4.3.2","article-title":"Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications","volume":"4","author":"Jerrell","year":"2010","journal-title":"Clinical Schizophrenia and Related Psychoses"},{"key":"10.1016\/j.psychres.2014.01.011_bib66","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/archpsyc.1981.01780360103012","article-title":"Plasma MHPG in rapid cyclers and healthy twins","volume":"38","author":"Jimerson","year":"1981","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib67","first-page":"45","article-title":"Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients","volume":"15","author":"Jimerson","year":"1980","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib68","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4088\/JCP.10m06320","article-title":"Alcohol use disorders in schizophrenia: a national cohort study of 12,653 patients","volume":"72","author":"Jones","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib69","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1017\/S1461145708008845","article-title":"Enhanced alpha1 adrenergic sensitivity in sensorimotor gating deficits in neonatal ventral hippocampus-lesioned rats","volume":"11","author":"Kamath","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib70","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000118821","article-title":"Plasma free 3-methoxy-4-hydroxyphenylglycol in acute schizophrenics before and after treatment","volume":"25","author":"Kaneko","year":"1992","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2014.01.011_bib71","first-page":"389","article-title":"Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study","volume":"15","author":"Karniol","year":"1982","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0278-5846(90)90063-M","article-title":"Factors associated with increased noradrenaline levels in schizophrenic patients","volume":"14","author":"Kemali","year":"1990","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib73","first-page":"711","article-title":"Increased noradrenaline levels in CSF and plasma of schizophrenic patients","volume":"17","author":"Kemali","year":"1982","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib74","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1192\/bjp.137.5.458","article-title":"Some clinical and metabolic aspects of propranolol in chronic schizophrenia","volume":"137","author":"King","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.mehy.2009.09.040","article-title":"A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction","volume":"74","author":"Kinney","year":"2010","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.psychres.2014.01.011_bib76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainres.2010.01.008","article-title":"Prenatal and adult stress interplay\u2014behavioral implications","volume":"1320","author":"Kjaer","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib77","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.288.3.351","article-title":"Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction","volume":"288","author":"Ko","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.psychres.2014.01.011_bib78","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archpsyc.1988.01800330072009","article-title":"Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtype","volume":"45","author":"Ko","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib79","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archpsyc.1989.01810100064012","article-title":"Antidepressants in \u2018depressed\u2019 schizophrenic inpatients. A controlled trial","volume":"46","author":"Kramer","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib80","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.pnpbp.2005.04.003","article-title":"Noradrenergic hypothesis of schizophrenia","volume":"29","author":"Lechin","year":"2005","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib81","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/01612840903200019","article-title":"The relationship between symptoms and stress in adolescents with schizophrenia","volume":"30","author":"Lee","year":"2009","journal-title":"Issues in Mental Health Nursing"},{"key":"10.1016\/j.psychres.2014.01.011_bib82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0920-9964(99)00080-8","article-title":"Lack of effect of an early stressful life event on sensorimotor gating in adult rats","volume":"41","author":"Lehmann","year":"2000","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib83","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1017\/S0033291708004613","article-title":"Impact of stress on paranoia: an experimental investigation of moderators and mediators","volume":"39","author":"Lincoln","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.psychres.2014.01.011_bib84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1192\/bjp.137.2.126","article-title":"Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients","volume":"137","author":"Lindstrom","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib85","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00004714-199510000-00009","article-title":"Clonidine plus haloperidol in the treatment of schizophrenia\/psychosis","volume":"15","author":"Maas","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib86","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archpsyc.1993.01820230041004","article-title":"Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study","volume":"50","author":"Maier","year":"1993","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib87","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1192\/bjp.148.6.701","article-title":"Does propranolol have an antipsychotic effect? A placebo-controlled study in acute schizophrenia","volume":"148","author":"Manchanda","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib88","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/sj.npp.1300700","article-title":"Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats","volume":"30","author":"Marrs","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib89","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1161\/CIRCULATIONAHA.104.519652","article-title":"Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years","volume":"111","author":"Masuo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.psychres.2014.01.011_bib90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1601-183X.2005.00172.x","article-title":"Effects of repeated maternal separation on prepulse inhibition of startle across inbred mouse strains","volume":"5","author":"Millstein","year":"2006","journal-title":"Genes Brain and Behavior"},{"key":"10.1016\/j.psychres.2014.01.011_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.43.1.1","article-title":"Effect of intravenous propranolol on QT interval. A new method of assessment","volume":"43","author":"Milne","year":"1980","journal-title":"British Heart Journal"},{"key":"10.1016\/j.psychres.2014.01.011_bib92","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0306-4530(00)00024-X","article-title":"Multihormonal responses to clonidine in patients with affective and psychotic symptoms","volume":"25","author":"Mokrani","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2014.01.011_bib93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/appi.ajp.159.3.443","article-title":"Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study","volume":"159","author":"Myin-Germeys","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib94","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/nn.3549","article-title":"Common medial frontal mechanisms of adaptive control in humans and rodents","volume":"16","author":"Narayanan","year":"2013","journal-title":"Nature Neuroscience"},{"issue":"9","key":"10.1016\/j.psychres.2014.01.011_bib95","first-page":"25","article-title":"Medical risk in patients with bipolar disorder and schizophrenia","volume":"67","author":"Newcomer","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib96","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib97","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0002-9149(71)90037-3","article-title":"Clonidine: a new antihypertensive agent","volume":"28","author":"Onesti","year":"1971","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.psychres.2014.01.011_bib98","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/schbul\/sbs071","article-title":"Clonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication","volume":"39","author":"Oranje","year":"2013","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2014.01.011_bib99","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbs071","article-title":"Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication","author":"Orange","year":"2013","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2014.01.011_bib100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psychres.2004.04.002","article-title":"Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol","volume":"127","author":"Oranje","year":"2004","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib101","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.139.2.105","article-title":"Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo","volume":"139","author":"Peet","year":"1981","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib102","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archgenpsychiatry.2007.15","article-title":"Family-based association study of lithium-related and other candidate genes in bipolar disorder","volume":"65","author":"Perlis","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib103","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(01)01184-2","article-title":"Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania","volume":"50","author":"Perry","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-004-1976-6","article-title":"Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats","volume":"178","author":"Pouzet","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.psychres.2014.01.011_bib105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00213-005-2193-7","article-title":"Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors","volume":"180","author":"Powell","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.psychres.2014.01.011_bib106","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2011.03.022","article-title":"Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls","volume":"129","author":"Pruessner","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib107","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1192\/bjp.143.2.151","article-title":"Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication","volume":"143","author":"Pugh","year":"1983","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib108","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pharmthera.2006.11.006","article-title":"Adrenergic pharmacology and cognition: focus on the prefrontal cortex","volume":"113","author":"Ramos","year":"2007","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.psychres.2014.01.011_bib109","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.neurobiolaging.2007.02.003","article-title":"Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals","volume":"29","author":"Ramos","year":"2008","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.psychres.2014.01.011_bib110","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.biopsych.2005.05.022","article-title":"The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys","volume":"58","author":"Ramos","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib111","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-5618.2005.00183.x","article-title":"An investigation of prepulse inhibition in pediatric bipolar disorder","volume":"7","author":"Rich","year":"2005","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.psychres.2014.01.011_bib112","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/schbul\/sbi044","article-title":"Synthesizing schizophrenia: a bottom-up, symptomatic approach","volume":"31","author":"Robbins","year":"2005","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2014.01.011_bib113","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib114","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0028-3908(94)90074-4","article-title":"Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats","volume":"33","author":"Sipes","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2014.01.011_bib115","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00424-011-1006-6","article-title":"Enhanced catecholamine release in mice expressing PKB\/SGK-resistant GSK3","volume":"462","author":"Siraskar","year":"2011","journal-title":"Pflugers Archives"},{"key":"10.1016\/j.psychres.2014.01.011_bib116","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/ajh\/3.11.823","article-title":"Elevated insulin, norepinephrine, and neuropeptide Y in hypertension","volume":"3","author":"Solt","year":"1990","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.psychres.2014.01.011_bib117","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1592\/phco.26.2.162","article-title":"Do randomized controlled trials always trump case reports? A second look at propranolol and depression","volume":"26","author":"Steffensmeier","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.psychres.2014.01.011_bib118","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1176\/ajp.140.4.396","article-title":"CSF monoamine metabolites in mania","volume":"140","author":"Swann","year":"1983","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib119","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00213-006-0374-7","article-title":"Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome","volume":"186","author":"Swerdlow","year":"2006","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.psychres.2014.01.011_bib120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/ajp.149.1.22","article-title":"Are schizophrenia and affective disorder related? A selective literature review","volume":"149","author":"Taylor","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib121","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2007-1017272","article-title":"Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH","volume":"19","author":"Tripodianakis","year":"1986","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib122","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2478\/v10039-011-0016-0","article-title":"Blood pressure in relation to neurogenic, inflammatory and endothelial dysfunction biomarkers in patients with treated essential arterial hypertension","volume":"56","author":"Tycinska","year":"2011","journal-title":"Advances in Medical Sciences"},{"key":"10.1016\/j.psychres.2014.01.011_bib123","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-8993(97)00416-2","article-title":"The locus coeruleus noradrenergic system in the rat brain studied by dual-probe microdialysis","volume":"763","author":"van Gaalen","year":"1997","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib124","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0920-9964(91)90032-M","article-title":"Dopamine and norepinephrine activity in schizophrenia. An integrative perspective","volume":"4","author":"van Kammen","year":"1991","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0165-1781(89)90145-5","article-title":"Clonidine treatment of schizophrenia: can we predict treatment response?","volume":"27","author":"van Kammen","year":"1989","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.1990.01810140061009","article-title":"Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited","volume":"47","author":"van Kammen","year":"1990","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib127","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archgenpsychiatry.2009.64","article-title":"Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder","volume":"66","author":"Van Snellenberg","year":"2009","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0920-9964(99)00069-9","article-title":"Efficacy of beta-blocker supplementation for schizophrenia: a systematic review of randomized trials","volume":"41","author":"Wahlbeck","year":"2000","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.01.011_bib129","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1176\/ps.2009.60.8.1059","article-title":"Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey","volume":"60","author":"Weber","year":"2009","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.psychres.2014.01.011_bib130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2004.05.033","article-title":"Proposal for a noradrenaline hypothesis of schizophrenia","volume":"28","author":"Yamamoto","year":"2004","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.01.011_bib131","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0361-9230(94)90167-8","article-title":"Possible noradrenergic dysfunction in schizophrenia","volume":"35","author":"Yamamoto","year":"1994","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.psychres.2014.01.011_bib132","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.4.5945.633","article-title":"Propranolol in the control of schizophrenic symptoms","volume":"4","author":"Yorkston","year":"1974","journal-title":"British Medical Journal"},{"key":"10.1016\/j.psychres.2014.01.011_bib133","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(77)91427-1","article-title":"Propranolol as an adjunct to the treatment of schizophrenia","volume":"2","author":"Yorkston","year":"1977","journal-title":"The Lancet"},{"key":"10.1016\/j.psychres.2014.01.011_bib134","first-page":"175","article-title":"Safeguards in the treatment of schizophrenia with propranolol","volume":"4","author":"Yorkston","year":"1976","journal-title":"Postgraduate Medical Journal Supplements"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811400047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811400047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:06:51Z","timestamp":1746115611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811400047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S016517811400047X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2014.01.011","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is elevated norepinephrine an etiological factor in some cases of schizophrenia?","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2014.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}